Qianhui Ren

No ORCID on file · 13 papers in corpus · active 2022-2026

Study types

  • article 7
  • other 4
  • preprint 1
  • review 1

Condition tags

  • adenomyosis 7
  • endometriosis 6
  • dysmenorrhea 3
  • chronic_pelvic_pain 1
  • endometrioma 1
other 2026
Redox biology ·doi:10.1016/j.redox.2026.104101

Endometriosis (EM) is driven by immune dysregulation and macrophage dysfunction, yet the underlying mechanisms remain unclear. Here, metabolomic profiling revealed excessive itaconate accumulation in EM lesions, primarily due to elevated ci…

other 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03781-2

PURPOSE: Endometriosis (EM) is a chronic inflammatory gynecological disorder characterized by ectopic endometrial-like lesions, where aberrant angiogenesis is a hallmark driving lesion establishment and progression. However, the transcripti…

article 2025
BMC medicine ·doi:10.1186/s12916-025-04369-4

BACKGROUND: Endometriosis (EM) exhibits localised iron overload. However, the contribution of ferroptosis to EM pathogenesis remains unclear. We investigated how iron overload affects CD8⁺ T cell immune function and the underlying ferroptot…

article 2024
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2024.2409918

OBJECTIVE: We carried out this study to explore the possibility of initiating goserelin therapy during the non-menstrual period in patients diagnosed with adenomyosis. METHODS: 115 premenopausal adenomyosis patients were enrolled and divid…

other 2024
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-024-01536-5

Endometriosis diagnosis is usually delayed. The gold standard for diagnosing endometriosis is laparoscopy, which is invasive and accompanied by several risks. Currently, there are no effective non-invasive biomarkers for diagnosing endometr…

article 2024
BMC microbiology ·doi:10.1186/s12866-024-03339-9

BACKGROUND: Adenomyosis is a commonly observed benign gynecological disease that affects the quality of life and social psychology of women of childbearing age. However, because of the unknown etiology and incidence of adenomyosis, its path…

article 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01145-y

BACKGROUND: To determine whether there is a correlation between stiffness measured by strain elastography and the severity of dysmenorrhea and to determine the value of elastography in evaluating severe dysmenorrhea in patients with adenomy…

article 2023
Journal of psychosomatic obstetrics and gynaecology ·doi:10.1080/0167482x.2023.2214842

The management of endometriosis has been complicated by the COVID-19 pandemic. We aimed to introduce the establishment and application of a new follow-up method during the COVID-19 pandemic—the electronic follow-up (e-follow-up) platform fo…

article 2023
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.05.003
review 2023
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-07034-4

BACKGROUND: Adenomyosis is a benign disorder characterized by the presence of ectopic endometrial glands and stroma within the myometrium. The main clinical manifestations of adenomyosis are dysmenorrhea, menorrhagia, and infertility, which…

preprint 2023
·doi:10.21203/rs.3.rs-3317589/v1
other 2022
Journal of clinical medicine ·doi:10.3390/jcm11185286

The absence of clinically objective methods to evaluate adenomyosis-associated pain and the poor understanding of its pathophysiology lead to treatment limitations. We conducted a resting-state functional magnetic resonance imaging study wi…

article 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2160435

OBJECTIVE: This prospective cohort study aimed to compare the clinical efficacy and safety of goserelin 10.8 mg administered trimonthly with goserelin 3.6 mg administered monthly in premenopausal females with symptomatic adenomyosis. METHOD…